期刊文献+

固定型腔内后装施源器治疗宫颈癌的剂量分布特点 被引量:1

Dose Distribution Trait of Fixed Intrauterine Tee Source Applicator
下载PDF
导出
摘要 目的:研究固定型腔内后装施源器及标准腔内后装施源器的剂量分布特点,评价固定型腔内施源器是否符合临床剂量学要求。方法:比较固定型腔内后装施源器和标准型腔内施源器的等剂量曲线分布图,并根据腔内近距离放疗中剂量分布与距离平方成反比的剂量学特点,按照施源器材料中的指数衰减及吸收系数,计算出两种施源器x和y轴两个方向上的剂量比。结果:标准Ⅲ通腔内施源器和固定Ⅲ通腔内施源器等剂量曲线分布图通过TPS优化,图形基本一致:在冠状面上等剂量曲线呈扁梨行,宫颈、阴道剂量大于宫体剂量,在横断面上等剂量曲线呈扁椭圆形;且固定型扁平腔内施源器源中心到模表面距离为0.5 cm,而标准Ⅲ通腔内施源器从源中心到模表面距离为1 cm,通过计算可知当r=0.5 cm,l=1.0 cm时其剂量比大于l=1.5 cm时的剂量比,因此给予A点相同剂量所需要的时间较标准腔内后装施源器要短,由于治疗时间短,膀胱直肠所受剂量就小,通过优化,直肠剂量只有A点剂量的70%,而宫颈粘膜表面剂量比经典施源器剂量要高出45%。结论:固定型腔内后装施源器剂量分布符合临床剂量学要求,且优于标准施源器,同时由于使用简单方便,不用模拟机拍片,剂量计算模式也固定,更适合宫颈癌患者多的治疗中心使用。 This study was aimed to research the dose distribution of the intrauterine fixed tee source applicator and traditional one, and evaluate whether or not this applicator meet the requirement of clinical dosimetry. Methods: The isodose curve cattergram of fixed intrauterine tee source applicator was compared with standard apparatus. Dose distribution was the inverse to the square of the distance in intracavitary brachytherapy, so the dose ratios in x- and y-direction of the two applicator were calculated by the coefficient of the exponential decay and the absorption. Results: The isodose curve cattergram of standard and fixed intrauterine tee source applicator, optimized by TPS, were nearly accordant. They displayed a fiat pearl pattern in coronal plane, and flat oval pattern in cross section. The dose in cervix uteri and vagina was greater than that in corpus uteri. The 0.5 cm distance from the center of the source to the surface was applied in fixed applicator, and 1.0 cm in standard apparatus, and larger dose ratio were calculated when r =0.5 cm,ι=1.0 cm than ι=1.5 cm. The lapse of time to reach the same dosage in point A of the fixed applicator was much shorter than traditional one. It had saddle form dose distribution, with high dosage in the cervix and low dosage in the bladder. When optimized by the fixed applicator, dose adopted in the rectum wasonly 70% of the A point, and was 45% higher in the cervix membrane surface than that in the classic one. Conclusions: Dose distribution of fixed tee source applicator is more rational than traditional device, and this apparatus is more suitable for caner centers with a lot of patients.
出处 《中国医学物理学杂志》 CSCD 2012年第5期3613-3616,共4页 Chinese Journal of Medical Physics
关键词 宫颈癌 腔内后装 固定型腔内施源器 标准型腔内施源器 剂量分布 cervical carcinoma/Intracavitary brachytherapy fixed tee source applicator/traditionalal applicator dosimetry distributing
  • 相关文献

参考文献7

  • 1孙建衡.妇科恶性肿瘤放射疗法现状[J].中国医学科学院学报,2003,25(4):481-483. 被引量:11
  • 2ICRU第38份报告:妇科学腔内治疗的剂量和容积规格参数[M].贝塞斯达:国际辐射学单位委员会,1985:1-18.
  • 3纳格 S,埃里克森 B,托马德森 B,等.全美近距离放疗协会宫颈癌高剂量率近距离放疗的推荐规范[J].肿瘤放射生物生理学杂志,2000,48(1):201-211.
  • 4姜迎宵,王明臣,王培合,李勇,郝福荣,马瑞忠.子宫颈癌调强放射治疗临床分析[J].中国肿瘤临床与康复,2010,17(2):118-121. 被引量:4
  • 5纳格 S,奥通 C,扬 D,等.全美近距离放疗协会对美国宫颈癌的近距离放射治疗的观察[J].妇科肿瘤,1999,73(1):111-118.
  • 6杨勇琴,王静,张镇君.两种不同腔内后装施源器治疗宫颈癌的临床观察[J].临床肿瘤学杂志,2008,13(12):1115-1118. 被引量:4
  • 7波特 R,海耶-梅德 C,林伯杰 EV,等.GEC ESTRO妇科工作组的建议(Ⅱ):3维模式宫颈癌近距离治疗计划概念和术语-3维剂量容积参数和3D影像的解剖[J].放射物理学,放射生物学基础,2006,78:67-77.

二级参考文献21

  • 1盛修贵,孙建衡,周春晓.Ⅰ期卵巢上皮癌的治疗研究——辅助放射治疗评价[J].中华肿瘤杂志,1996,18(4):314-316. 被引量:2
  • 2陈真云,盛修贵,李慧芹,李庆水,李大鹏,马志芳,马悦冰,李庆菊.调强放射治疗在宫颈癌术后治疗中的临床研究[J].中国实用妇科与产科杂志,2007,23(7):539-542. 被引量:16
  • 3International Commission of Radiation Units and Measurements. ICRU report 38 : Dose and volume specification for reporting intracavitary therapy in gynecology [ M ]. Bethesda: International Commission of Radiation Units and Measurements, 1985:1 - 18.
  • 4Nag S, Erickson B,Thomadsen B, et al. The American brachytherapy society recommendations for high dose rate brachytherapy for carcinoma of the cervix[ J]. Int J Radiat Oncol Biol Phys,2000, 48(1) :201 -211.
  • 5Nag S, Orton C, Young D, et al. The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States [J]. Gynecol Oncol, 1999,73 ( 1 ) : 111 -118.
  • 6Hamberger AD, Unal A, Gershenson DM, et al. Analysis of the sever complications of irradiation of carcinoma of the cervix: whole pelvis irradiation and intracavitary radium[ J]. Int J Radiat Oncol Biol Phys, 1983,9:367 -371.
  • 7Rao GG, Rogars P, Drake RD,et al. Phase Ⅰ clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer [ J ]. Gynecol Oncol, 2005,96 (1) :168.
  • 8Georg P, Georg D, Hillbrand M, et, al. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies [ J ]. Radiother Oncol,2006 ,80 ( 1 ) : 19 -26.
  • 9van de Bunt L, van der Heide UA, Ketelaars M, et al. Conventional, confonnal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression[ J]. Int J Radiat Oncol Biol Phys, 2006,64 ( 1 ) : 189-196.
  • 10Adli M, Mayr NA, Kaiser HS, et al. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer[ J] .? Int J Radiat Oncol Biol Phys, 2003,57 ( 1 ) :230-238.

共引文献16

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部